Edgestream Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.38M | Buy |
6,548
+4,112
| +169% | +$886K | 0.05% | 581 |
|
|
2025
Q4 | $501K | Sell |
2,436
-20,392
| -89% | -$3.84M | 0.01% | 813 |
|
|
2025
Q3 | $3.58M | Buy |
22,828
+18,878
| +478% | +$2.92M | 0.1% | 368 |
|
|
2025
Q2 | $664K | Sell |
3,950
-12,051
| -75% | -$1.79M | 0.02% | 699 |
|
|
2025
Q1 | $2.2M | Buy |
16,001
+8,688
| +119% | +$1.11M | 0.07% | 461 |
|
|
2024
Q4 | $865K | Buy |
7,313
+5,066
| +225% | +$591K | 0.04% | 594 |
|
|
2024
Q3 | $248K | Sell |
2,247
-13,926
| -86% | -$1.46M | 0.01% | 785 |
|
|
2024
Q2 | $1.59M | Sell |
16,173
-6,749
| -29% | -$688K | 0.08% | 402 |
|
|
2024
Q1 | $2.56M | Buy |
22,922
+20,139
| +724% | +$2.17M | 0.13% | 280 |
|
|
2023
Q4 | $281K | Sell |
2,783
-913
| -25% | -$90.6K | 0.02% | 735 |
|
|
2023
Q3 | $321K | Sell |
3,696
-4,446
| -55% | -$402K | 0.03% | 693 |
|
|
2023
Q2 | $770K | Sell |
8,142
-28,661
| -78% | -$2.42M | 0.07% | 416 |
|
|
2023
Q1 | $2.78M | Buy |
36,803
+11,476
| +45% | +$866K | 0.31% | 79 |
|
|
2022
Q4 | $1.95M | Buy |
25,327
+13,225
| +109% | +$1M | 0.22% | 150 |
|
|
2022
Q3 | $807K | Buy |
+12,102
| New | +$767K | 0.06% | 298 |
|
|
2022
Q2 | – | Sell |
-8,832
| Closed | -$501K | – | 519 |
|
|
2022
Q1 | $501K | Sell |
8,832
-6,199
| -41% | -$332K | 0.04% | 422 |
|
|
2021
Q4 | $774K | Buy |
+15,031
| New | +$737K | 0.05% | 346 |
|
|
2021
Q1 | – | Sell |
-42,939
| Closed | -$2.3M | – | 381 |
|
|
2020
Q4 | $2.3M | Sell |
42,939
-113,688
| -73% | -$5.9M | 0.12% | 217 |
|
|
2020
Q3 | $7.35M | Buy |
156,627
+66,015
| +73% | +$3.39M | 0.48% | 66 |
|
|
2020
Q2 | $4.73M | Buy |
90,612
+25,071
| +38% | +$1.29M | 0.25% | 121 |
|
|
2020
Q1 | $3.14M | Buy |
+65,541
| New | +$3.4M | 0.29% | 105 |
|
|
2017
Q3 | – | Sell |
-2,722
| Closed | -$212K | – | 121 |
|
|
2017
Q2 | $212K | Sell |
2,722
-895
| -25% | -$67.5K | 0.08% | 119 |
|
|
2017
Q1 | $295K | Buy |
+3,617
| New | +$285K | 0.13% | 124 |
|
|
2016
Q2 | – | Sell |
-4,002
| Closed | -$328K | – | 45 |
|
|
2016
Q1 | $328K | Buy |
4,002
+691
| +21% | +$56.2K | 0.37% | 59 |
|
|
2015
Q4 | $296K | Sell |
3,311
-859
| -21% | -$72.9K | 0.84% | 45 |
|
|
2015
Q3 | $320K | Sell |
4,170
-6,382
| -60% | -$533K | 0.56% | 37 |
|
|
2015
Q2 | $883K | Buy |
+10,552
| New | +$932K | 0.61% | 43 |
|
|
2014
Q4 | – | Sell |
-3,196
| Closed | -$239K | – | 61 |
|
|
2014
Q3 | $239K | Buy |
+3,196
| New | +$233K | 0.21% | 71 |
|
Other funds holding CAH
VCM
VPM
Edgestream Partners's CAH Position: Q1 2026 in Review
Edgestream Partners increased its Cardinal Health (CAH) stake by 169% in Q1 2026, buying an estimated $886K and bringing the position to 6,548 shares worth $1.38M. The position accounts for 0.05% of the portfolio, ranked #581.
Edgestream Partners first reported a position in CAH in Q3 2014 and has held it in 28 quarters since. The position peaked at $7.35M in Q3 2020. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Edgestream Partners held 6,548 shares of Cardinal Health worth $1.38M as of Q1 2026.
- Edgestream Partners bought 4,112 Cardinal Health shares in Q1 2026, an estimated $886K.
- Cardinal Health made up 0.05% of Edgestream Partners's portfolio in Q1 2026, its #581 holding.
- Edgestream Partners first reported a position in Cardinal Health in Q3 2014 and has held it in 28 quarters since.
- Edgestream Partners's Cardinal Health position peaked at $7.35M in Q3 2020.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.